Diabetes Mellitus, Insulin-Dependent Clinical Trial
Official title:
Subject: A Blinded Randomized Trial: the Effect of Guided Imagery in Children With Type 1 Diabetes Mellitus on Glucose Levels and on Glycemic Control
| Verified date | January 2015 |
| Source | Assaf-Harofeh Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Israel: Ministry of Health |
| Study type | Interventional |
Background: Pediatric patients with type 1 diabetes mellitus are known to be a challenging
group for achieving recommended glycemic control. Coping with the demands of self-managing
IDDM in children and adolescents can be a formidable task, requiring a healthy and balanced
diet, monitoring and regular insulin injections. Most patients are non-compliant to the
treatment. A number of controlled studies have examined the efficiency of psychosocial
interventions for improving compliance and glycemic control among diabetic youth. None has
examined the effectiveness of guided imagery in treatment of type 1 diabetes mellitus.
Primary Objective: To asses simultaneously the effect of listening to auditory guided
imagery and blood glucose variability, compared to variability in blood glucose while
listening to songs.
Secondary Objective To assess the effect of routine auditory guided imagery to glycemic
control and quality of life in children with type 1 diabetes mellitus, compared to listening
listening to songs.
Methods:
Subjects: 14 youth ages 7-16 years with type 1 diabetes mellitus , for at least 6 months,
and not during the honey moon period will be recruited, and will be blindly randomized to
receive intervention (auditory guided imagery group) or control (regular auditory music).
Protocol:
Design: A randomized Controlled Blinded Study Intervention: 14 randomly numbered CD's will
be prepared at study initiation, half containing auditory guided imagery and half containing
music.
Study protocol: After an initial check up, including HbA1C levels, and explanation of study
procedures the participants will be given either the intervention or the control CD, to be
used twice a day for five days. During this period continuous glucose monitoring will be
performed. On days one and five the procedure will take place while the participants are
connected to biofeedback. QOL questionnaires will be completed at the beginning of day one,
or before.
In the second part of the study the children will use the intervention / control CD at home
twice a week for 12 weeks. At the end of the study period they will again be evaluated,
including HbA1C, and all subjects will again complete QOL questionnaires
| Status | Completed |
| Enrollment | 13 |
| Est. completion date | May 2012 |
| Est. primary completion date | May 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 7 Years to 16 Years |
| Eligibility |
Inclusion Criteria: - Type 1 diabetes mellitus for longer than 6 months - Insulin requirements of more than 0.4 units/kg/day for at least 3 months - Age 7-16 years - Agreement of parents or guardian to participate in the study - Agreement and wiliness of child to participate in the study Exclusion Criteria: - Children with cognitive impairment which prevents them from using guided imagery - Unable to understand Hebrew - Hearing defect - Attention deficit disorder |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| Israel | Assaf Haroffeh Medical center | Zerifin |
| Lead Sponsor | Collaborator |
|---|---|
| Assaf-Harofeh Medical Center |
Israel,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Blood glucose values before and after listening to the recording. | Blood glucose variability of teenagers before and after listening to auditory guided imagery, compared to the blood glucose variability of teenagers before and after listening to music. The blood glucose values will be measured by continuous glucose monitoring system (CGMS). | 1 week | No |
| Secondary | The delta of HA1C between before and after three months of periodic listening to auditory guided imagery, compared to listening to music. | Average of deltas of HA1C between before and after three months of peridic listening to auditory guided imagery, compared to listening to music. | 3 months | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01322789 -
Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT00035750 -
Risk Factors for Atherogenesis in Type 1 Diabetes
|
N/A | |
| Completed |
NCT00005754 -
Coronary Artery Calcification in Type 1 Diabetes
|
N/A | |
| Completed |
NCT00005474 -
Markers and Mechanisms of Macrovascular Disease in IDDM
|
N/A | |
| Completed |
NCT01236365 -
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
|
Phase 3 | |
| Completed |
NCT01216618 -
Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies
|
Phase 3 | |
| Completed |
NCT00071409 -
Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes
|
Phase 2 | |
| Completed |
NCT00069537 -
Continuous Glucose Monitors for Children With Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT05168657 -
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
|
N/A | |
| Withdrawn |
NCT00297635 -
Telemetric Glucose Data Acquisition During Initiation of Insulin Pump Therapy
|
Phase 2 | |
| Completed |
NCT00184821 -
Ischemic Injury and Ischemic Preconditioning in Diabetes
|
N/A | |
| Completed |
NCT00073255 -
Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)
|
Phase 1 | |
| Completed |
NCT00690066 -
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
|
Phase 2 | |
| Active, not recruiting |
NCT04078308 -
Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT00069628 -
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer
|
Phase 4 | |
| Completed |
NCT00044395 -
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
|
Phase 3 | |
| Completed |
NCT00044408 -
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
|
Phase 3 | |
| Completed |
NCT00069615 -
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in Children
|
Phase 4 | |
| Completed |
NCT00005539 -
Wisconsin Epidemiological Study of Cardiovascular Disease in Type 1 Diabetes
|
N/A | |
| Completed |
NCT04689685 -
The RADAR Study - Wearable-Based Dysglycemia Detection and Warning in Diabetes
|